AARON STIRLING: Open Payments
NPI 1588142533 · ESCONDIDO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,655 in 37 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,655
Food & beverage: $1,371Education: $185Long term medical supply or device loan: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $234 |
| Eisai Inc. | 2 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $140 |
| AstraZeneca Pharmaceuticals LP | 5 | $137 |
| Novartis Pharmaceuticals Corporation | 2 | $131 |
| Amgen Inc. | 1 | $125 |
| SOBI, INC | 2 | $124 |
| Merck Sharp & Dohme LLC | 4 | $121 |
| Gilead Sciences, Inc. | 2 | $114 |
| BeOne Medicines USA, Inc. | 2 | $53 |
Products named: Lenvima, RYBREVANT, FRUZAQLA, KISQALI, BLINCYTO, KEYTRUDA, Trodelvy, ERLEADA.
Industry payments across CA — which companies pay providers there.
